Legal Representation
Attorney
DAVID R. STEVENS
USPTO Deadlines
Next Deadline
155 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 3, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 2, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 1, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 7, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 26, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 26, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 20, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 31, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 31, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 31, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 31, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 1, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 24, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 7, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medical diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular diagnostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical molecular prognostic test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical diagnostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Medical prognostic molecular treatment stratification test kits comprised of primers and probes for quantitative polymerase chain reaction (PCR) for analysis of tumor tissue in the field of oncology; Formalin fixed, paraffin embedded (FFPE) diagnostic kits comprised of medical diagnostic reagents and assays for testing of tumor tissue for use in risk segregation and managing disease treatment, namely, cancer
Additional Information
Pseudo Mark
RISK REVEAL
Classification
International Classes
005